The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.

@article{Peng2011TheCB,
  title={The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.},
  author={S. Peng and X. Liu and S. Huang and Z. Li and H. Pan and Wanxin Zhen and K. Luk and X. E. Guo and W. Lu},
  journal={Bone},
  year={2011},
  volume={49 6},
  pages={
          1290-8
        }
}
  • S. Peng, X. Liu, +6 authors W. Lu
  • Published 2011
  • Chemistry, Medicine
  • Bone
  • BACKGROUND The mechanism for the uncoupling effects of Sr on bone remains to be evaluated. Osteoblasts play important roles in osteoclastogenesis through regulating receptor activated nuclear factor kappa B (RANK) ligand (RANKL) and osteoprotegerin (OPG) expression. We hypothesize that OPG plays an important role in the cross-talk between osteoclasts and osteoblasts in response to Sr treatment. MATERIALS AND METHODS MC3T3E1 cells were treated with Sr chloride (0-3 mM) and conditioned media… CONTINUE READING
    84 Citations
    Strontium inhibits osteoclastogenesis by enhancing LRP6 and β-catenin-mediated OPG targeted by miR-181d-5p
    • T. Sun, Z. Li, +8 authors S. Peng
    • Chemistry, Medicine
    • Journal of Cell Communication and Signaling
    • 2018
    • 2
    Strontium signaling: molecular mechanisms and therapeutic implications in osteoporosis.
    • 185
    The synergistic effects of Sr and Si bioactive ions on osteogenesis, osteoclastogenesis and angiogenesis for osteoporotic bone regeneration.
    • 68
    Strontium substitution in apatitic CaP cements effectively attenuates osteoclastic resorption but does not inhibit osteoclastogenesis.
    • 43
    Deregulation of Bone Forming Cells in Bone Diseases and Anabolic Effects of Strontium-Containing Agents and Biomaterials
    • 26
    • Highly Influenced
    • PDF
    Biomaterial based treatment of osteoclastic/osteoblastic cell imbalance - Gelatin-modified calcium/strontium phosphates.
    • B. Kruppke, Alena-Svenja Wagner, +7 authors Thomas Hanke
    • Materials Science, Medicine
    • Materials science & engineering. C, Materials for biological applications
    • 2019
    • 6

    References

    SHOWING 1-10 OF 36 REFERENCES
    Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
    • 350
    • PDF
    Osteoprotegerin deficiency attenuates strontium‐mediated inhibition of osteoclastogenesis and bone resorption
    • S. Peng, X. Liu, +4 authors W. Lu
    • Medicine, Biology
    • Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
    • 2011
    • 41
    Osteoprotegerin ligand regulates osteoclast adherence to the bone surface in mouse calvaria.
    • 63
    In vitro effects of S12911-2 on osteoclast function and bone marrow macrophage differentiation.
    • 227
    Osteoprotegerin Ligand Is a Cytokine that Regulates Osteoclast Differentiation and Activation
    • 4,999
    Negative Regulation of Osteoclastogenesis by Ectodomain Shedding of Receptor Activator of NF-κB Ligand*
    • 201
    • PDF
    Induction of a program gene expression during osteoblast differentiation with strontium ranelate.
    • 96